Current position:Home >Product >
7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinylidene]-β-D-ribofuranosyl]-7H -purin-6-amine
7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinylidene]-β-D-ribofuranosyl]-7H -purin-6-amine(1803127-57-2)
- Name: 7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinylidene]-β-D-ribofuranosyl]-7H -purin-6-amine
- Synonyms:
- Molecular Formula:
- Molecular Weight:
- CAS Registry Number:1803127-57-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1803127-57-2 7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinylidene]-尾-D-ribofuranosyl]-7H -purin-6-amine
Assay:97% Appearance:Contact us for details Package:According to the requirements of customer Storage:Store in a tightly closed container in a cool and dry place. Transportation:Door to door by Fedex/DHL or by air Application:Research & Development
Min. Order:1Milligram
Supplier:NewCan Biotech Limited [
China (Mainland)] 
Premium
SupplierTel:0086-0571-86912261
Address:No. 99, Wangzhou Road, Liangzhu Street, Yuhang District,Hangzhou,Zhejiang,P.R.China
- Contact Suppliers
Other Product
- 1803126-51-3/Uridine, 4′-C -(difluoromethyl)-, 5′-[O ,O -bis(4-methoxyphenyl) phosphorothioate]
- 1803126-52-4/Uridine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-(1-methylethyl phosphate)
- 1803126-53-5/Uridine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803126-54-6/4′-C -(Difluoromethyl)-5-fluorouridine
- 1803126-68-2/Uridine, 4′-C -(difluoromethyl)-5-fluoro-, cyclic3′,5′-(1-methylethyl phosphate)
- 1803126-69-3/Uridine, 4′-C -(difluoromethyl)-5-fluoro-, cyclic3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803126-70-6/5-Chloro-4′-C -(difluoromethyl)uridine
- 1803126-83-1/Uridine, 5-chloro-4′-C -(difluoromethyl)-, cyclic3′,5′-(1-methylethyl phosphate)
- 1803126-84-2/Uridine, 5-chloro-4′-C -(difluoromethyl)-, cyclic3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803126-97-7/Cytidine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-(1-methylethyl phosphate)
- 1803126-98-8/Cytidine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803126-99-9/4′-C -(Difluoromethyl)-5-fluorocytidine
- 1803127-14-1/Cytidine, 4′-C -(difluoromethyl)-5-fluoro-, cyclic3′,5′-(1-methylethyl phosphate)
- 1803127-15-2/Cytidine, 4′-C -(difluoromethyl)-5-fluoro-, cyclic3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803127-28-7/Cytidine, 5-chloro-4′-C -(difluoromethyl)-, cyclic3′,5′-(1-methylethyl phosphate)
- 1803127-29-8/Cytidine, 5-chloro-4′-C -(difluoromethyl)-, cyclic3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803127-42-5/Adenosine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-(1-methylethyl phosphate)
- 1803127-43-6/Adenosine, 4′-C -(difluoromethyl)-, cyclic 3′,5′-[O -(1-methylethyl) phosphorothioate]
- 1803127-44-7/7-[4-C -(Difluoromethyl)-β-D-ribofuranosyl]-7H -purin-6-amine
- 1803127-57-2/7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinylidene]-β-D-ribofuranosyl]-7H -purin-6-amine
- 1803127-58-3/7-[4-C -(Difluoromethyl)-3,5-O -[(1-methylethoxy)phosphinothioylidene]-β-D-ribofuranosyl]-7H -purin-6-amine
- 1803127-73-2/2′-Deoxy-4′-C -(difluoromethyl)-2′-fluorouridine
- 1803127-86-7/Uridine, 2′-deoxy-4′-C -(difluoromethyl)-2′-fluoro-, cyclic 3′,5′-(1-methylethyl phosphate)
- 1803127-87-8/Uridine, 2′-deoxy-4′-C -(difluoromethyl)-2′-fluoro-, cyclic 3′,5′-[O -(1-methylethyl)phosphorothioate]
- 1803127-88-9/2′-Deoxy-4′-C -(difluoromethyl)-2′,5-difluorouridine
- 1803128-02-0/Uridine, 2′-deoxy-4′-C -(difluoromethyl)-2′,5-difluoro-, cyclic 3′,5′-(1-methylethylphosphate)
- 1803128-03-1/Uridine, 2′-deoxy-4′-C -(difluoromethyl)-2′,5-difluoro-, cyclic 3′,5′-[O -(1-methylethyl)phosphorothioate]
- 1803128-04-2/5-Chloro-2′-deoxy-4′-C -(difluoromethyl)-2′-fluorouridine
- 1803128-17-7/Uridine, 5-chloro-2′-deoxy-4′-C -(difluoromethyl)-2′-fluoro-, cyclic 3′,5′-(1-methylethylphosphate)
- 1803128-18-8/Uridine, 5-chloro-2′-deoxy-4′-C -(difluoromethyl)-2′-fluoro-, cyclic 3′,5′-[O -(1-methylethyl) phosphorothioate]